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Immunization with the autoantigen myelin basic protein (MBP)' causes exper-
imental allergic encephalomyelitis (EAE) (1), an autoimmune disease mediated
by antigen-specific class II-restricted T lymphocytes (1, 2). Recent studies have
shown that MBP-specific T cell clones mediate EAE, causing relapsing paralysis
and demyelination within the central nervous system (2, 3), features associated
with the human disease multiple sclerosis (MS) (4). By in vitro analysis of these
clones and the in vivo induction of EAE with MBP peptides, we have observed
that the encephalitogenic T cell response to the NH2 terminus of MBP in PL/J
and (PLSJ)F, mice is limited to a discrete population ofT lymphocytes that share
the same phenotypic class II (I-A°) restriction and similar NH2-terminal (1-9)
MBP specificity (5).
In this report, we have examined TCR a chain expression of individual NH2-
terminal MBP-specific T cell clones. These clones were analyzed with mAbs that
recognize TCR a chains of the variable (V) V08 TCR subfamily (6, 7). 14 of 18
(78%) PL/J T cell clones examined express a member of the V08 subfamily. By
Southern analysis with VQ- and Jo-specific gene probes, we examined four VQ8+
PL/J clones, demonstrating that each uses the same TCR Vo gene, V"8.2. Two
distinct V08.2-J#2 combinations were identified with two clones showing one type
of rearrangement and the other two sharing a separate Vs8.2Js2 combination.
These results represent the first molecular analysis of the TCR of T cell clones
that mediate autoimmune disease. Our results indicate that there is a restricted
use of TCR Vo genes in the autoimmune T cell response to the dominant ence-
phalitogenic NH2-terminal nonapeptide of MBP. We have also investigated
whether in vivo administration of an antibody to the antigen-specific TCR could
This work was supported by National Institutes of Health grants RO1NS-18235 and AI-22462, the
Rosenthal Foundation, and the Swim Foundation. H. Acha-Orbea is a fellow of the Swiss National
Science Foundation. N. E. Lee is a predoctoral student in the Cancer Biology Program. Address
correspondence to S. S. Zamvil, Department of Neurology, C-338, Stanford Medical School, Stan-
ford, CA 94305.
Abbreviations used in this paper: EAE, experimental allergic encephelomyelitis; MBP, myelin basic
protein, MS, multiple sclerosis; V, variable.
1586
￿
J. Exp. MED. © The Rockefeller University Press - 0022-1007/88/05/1586/11 $2.00
Volume 167 May 1988 1586-1596ZAMVIL ET AL.
￿
1587
inhibit T cell-mediated autoimmune disease . Our results demonstrate that an
mAb specific for the TCR V08 subfamily is effective in preventing autoimmune
encephalomyelitis.
Material and Methods
Mice.
￿
PL/J and (PL/J X SJL/J)FI [PLSJ]FI) female mice were purchased from the
Jackson Laboratory, Bar Harbor, ME, and housed in our animal facilities in the Depart-
ments of Genetics and Medical Microbiology, Stanford University, Stanford, CA.
Antigens.
￿
NH2-terminal MBP peptides were synthesized according to the sequences
for rat and bovine MBP by solid phase techniques as described previously (5). These
peptides contained >90% of the desired product as determined by high-pressure liquid
phase column (Merck & Co., Inc., Rahway, NJ) and amino acid analysis.
T Cell Clones.
￿
NH2-terminal MBP-specific T cell clones were isolated as described
previously, using intact MBP and MBP peptides (2, 3, 5). These clones were isolated from
homozygous PL/J mice, except clones F I-12 and F I-21, which were isolated from a
(PLSJ)FI mouse (3) . All clones described share the same class II (I-A°) restriction and
NH2-terminal MBP (1-9) specificity. Clones isolated from the same T cell line differed
in their TCR,3 chain rearrangement or their reactivity to TCR Vos-specific mAbs (Table
1) . Thus, none of the clones discussed are duplicate "sister" clones. T cell clones PJR-
25, PJB-20, PJpR-6 .2, PJpR-6.4, PJpBR-3.2, and FI-12 are encephalitogenic as described
(2, 3, 5) . T cell clones PJB-18, PJH-1 .5, and FI-21 are nonencephalitogenic (8). Other
NH2-terminal MBP-specific T cell clones have not been tested in vivo.
Proliferation Assay.
￿
The proliferative responses were determined as described previ-
ously (2) . Either 104 cloned T cells (Fig. 1) or 4 X 104 lymph node cells were cultures
with 5 X 105 -y-irradiated (3,000 rad) PL/J splenic APC in 0.2 ml culture media in 96-
well flat-bottomed microtitre plates (model 3072; Falcon Labware, Oxnard, CA). At 48
h of incubation, each well was pulsed with 1 ACi[sH]thymidine and harvested 16 h later.
The mean cpm thymidine incorporation was calculated for triplicate cultures. Standard
deviations from replicate cultures were within 10% mean value.
FACS Analysis.
￿
Each clone was stained with KJ16 (6) and anti-L3T4 (GK1 .5) (9) as
described previously (10). 5 X 105 T cells were incubated with 1 Ag biotin-conjugated
KJ16 (KJ16.133[6]) and 1 fag fluorescein-conjugated GK1 .5, followed by Texas red-avi-
din. KJ16 (red) fluorescence is shown on the vertical axis and L3T4 (green) fluorescence
on the horizontal axis. Immunofluorescence analysis was performed on a dual laser
FACS IV (Becton Dickinson Immunocytometry, Fullerton, CA) equipped with logarith-
mic amplifiers. Two-color staining data are presented as "contour plots", in which the
levels of green and red fluorescence per cell define the location on a two-dimensional
surface. The elevation at each location represents a 7% frequency of cells with a given
fluorescence intensity.
Southern Analysis.
￿
TCR probe VOc5., is a 280-bp Pst-Pvu II subdone of V#8.,(V#c5,.)
(reference 11). DNA probe 5'VO;5.2, a 0 .5-kb Pvu 11 fragment (1la), located 2 kb 5' of
V0K.2. J, 32-specific probe is a 1 .2-kb genomic probe encompassing J,2.1-2.7 (12). Liver and
T cell DNA were isolated with standard methods (13). Each sample, containing 10Ag
DNA, was digested to completion with either Xba I or Hind III, separated on 0.8% aga-
rose gels, and transferred to nitrocellulose filters. The filters were prehybridized at 42°C
for 4 h in 50% formamide, 5X SSPE, 100 jug/ml salmon sperm DNA, 1X Denhardt's
solution, 0.1% SDS, and l OmM Tris (pH 8.0). Hybridizations were performed in the
same buffer containing 5 X 106 cpm/ml of hexamer-primed probe for 20 h at 42°C.
The filters were washed in 2X SSC, 0.1% SDS at room temperature. They were washed
two more times for 1 h each at 60°C in 0 .2X SSC, 0 .1% SDS.
Induction of EAE .
￿
Induction of EAE with encephalitogenic MBP-specific T cell clone
PJR-25 has been described previously (2, 3). 5 X 106 ficoll-separated cells of clone PJR-
25 were injected intravenously into recipient (PLSJ)FI mice 6 h after intraperitoneal
injection of mAb. EAT was graded as described previously (2, 3): 0, no sign of EAE; 1,
decreased tail tone only; 2, mild paraparesis; 3, moderately severe papaparesis; 4, com-
plete paraplegia; 5, moribund.1588
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Results
TCR,6' Chain Expression ofNH2-terminalMBP-specific T Cells.
￿
20 MBP-specific
T cell clones (L3T4+ , Lyt2 -) were examined in this study. 18 of these clones
were isolated from 14 individual homozygous PL/J mice, and two clones were
isolated from a single (PLSJ)F1 mouse. These clones were isolated after immu-
nization with different forms of MBP and MBP peptides (2, 3, 5) . All 20 clones
share the same NH2-terminal nonapeptide specificity and class II (I-A°) restric-
tion (2, 3, 5). They are not alloreactive for foreign MHC class II molecules (8).
The NH2-terminal MBP-specificity of six representative clones is shown in Fig.
1. TCR a chain gene expression of these clones has been examined with mAbs
specific for the TCR Vs8 gene subfamily. The TCR-specific mAb KJ16 (6) rec-
ognizes a determinant associated with expression of two members of this TCR
V. gene subfamily (7) (also known as V.C5 [11]), VR8.1 (Vac5.1), and VR8.2 (VOG5.2).
The KJ16 phenotype is expressed by 16% of PL/J T lymphocytes. In contrast,
SJL/J mice do not express the Vp8 (KJ16) subfamily (6). Fig. 2 shows the FACS-
staining pattern with KJ16 for six representative T cell clones, four of which are
KJ16+ and two of which are KJ16- . Of the 18 PL/J clones, 14 (78%) are KJ16+
(Table I) . This high percentage of KJ16 + (V08+) clones is not an artifact from
examining duplicate "sister" clones isolated from the same T cell line . For those
lines where two clones are shown (Table I), the clones differed either in their
antibody reactivity or their TCR 0 chain gene rearrangement. Thus 78% KJ16'
clones is a minimum. When additional NH2-terminal MBP-specific sister clones
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FIGURE 1 . Encephalitogenic T
cell clones recognize the NH2
terminus of MBP. Synthetic MBP
peptides pR(rat) 1-11 (41~),
pRl-9 (-11-) and pB(bovine) 1-9
(-*-) were tested for their ability
to stimulate encephalitogenic
proliferative T cell clones. NH2-
terminal MBP peptides were syn-
thesized as described previously
using the sequences for rat and
bovine MBP (30) . Encephalito-
genic clones PJR-25 and FI-12
were isolated for individual
homozygous and (PI.SJ)FI mice,
respectively, after immunization
with intact rat MBP (5). Ence-
phalitogenic clone PJB-20 and
nonencephalitogenic clone PJB-
18 were isolated from individual
homozygous PL/J mice immu-
nizedwith bovine MBP (5). Ence-
phalitogenic clones PJpR-6.2 and
PJpR-6.4 were isolated from a
homozygous PLJ mouse immu-
nized with MBP peptide pRI-11 .
Proliferation assays were per-
formed as described in Materials
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FIGURE 2. NHz-terminal
MBP-specific T cell clones
were examined by FACS with
TCR Vß8-specific mAb KJ16 .
These are the same clones
examined in Fig. 1 . Each
clone was stained with KJ16
(6) and L3T4 (GKI .5) (refer-
ence 9) using two-color
immunofluorescence analysis .
The staining procedure was
performed as described pre-
viously (10) . T cells were incu-
bated with biotin-conjugated
KJ16 and fluorescein (green)-
conjugated GK1 .5, followed
by Texas red-avidin. Propi-
dium iodide was added to
stain dead cells. KJ16 (red)
fluorescence is shown on the
y-axis and L3T4 (green) fluo-
rescence on the x-axis . Immu-
nofluorescence analysis was
performed on a dual-laser
FACS equipped with logarith-
mic amplifiers . Two-color
staining data are presented as
"contour plots" in which the
levels of green and red fluo-
rescence per cell define the
location on a two-dimensional
surface. The elevation at each
location represent a 7% fre-
quency of cells with a given
fluorscence intensity .
were examined, we observed that 85% are KJ16+ (Vß8+ ) . Furthermore, the KJ16 -
clones are not stained with another n Ab, F23.1 (reference 14), which recognizes
a TCR determinant associated with the expression of all three members of the
Vß8 subfamily, Vß8,1, Vß8,2, and Vß8 .3 (7) .
The predominant use of the TCR Vß8 gene subfamily is not an in vitro cloning
artifact . We have examined the proliferative T cell response from MBP 1-11-
primed PL/J mice after FACS sorting L3T4+ lymph node cells with F23.1 into
L3T4 +/Vß8+ and L3T4+/Vß8 - subpopulations . When cultured with APC and
MBP 1-11, we have observed that >90%o of the proliferative T cell response to
MBP 1-11 occurs in the Vß8+ subpopulation (Acha-Orbea, H ., manuscript in
preparation) . Although the Vß8- subpopulation of MBP 1-11-primed lymph
node cells does not respond to MBP 1-11, this subpopulation does respond to
PPD, a positive control . Thus, by examining both in vitro isolated T cell clones
and primary cultures, we have shown that there is predominant usage of the
TCR Vßs subfamily in the autoimmune T lymphocyte response to the NH2 ter-
minus of MBP.
Genetic Analysis of TCR BChains of NH2-terminal MBP-specific T Cell
Clones . Southern blot analysis has been used to determine whether NH2-ter-1590
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TABLE I
Examination of NH2-terminal MBP-specific 7' Cell Clones with TCR Va8-specific
mAbs
T cell clones were stained with KJ16 (6) and F23.1 (14) as described in Materials and
Methods.
* Intact MBP and MBP peptides were used for selection as described previously (2, 3,
5). Peptide pRl-I1 is Ac-ASQKRPSQRHG andpBRI-I 1 is Ac-AAQKRPSQRHG (5).
'All clones were isolated from homozygous PLC mice except F,-12 and F,-21, which
were isolated from a(PLSJ)F, mouse (3). Clones PJB-l8 andPJB-20 were isolated from
the same T cell line. These twoclones differ in their(3 chain gene rearrangement (Fig.
3). Clones PJpR-5.2 and PJpR-5.3, PJpR-6.2 and PJpR-6.4, and PJpBR-3.1 and
PJpBR-3.2 were isolated from lines established from three separate mice. For each
pair, one member differed from the other in the reactivity to Vp-specific antibodies.
Therefore, none ofthe reported clones areduplicate "sister" clones. Tcell clones PJR-
25, PJB-20, PJpR-6.2, PJpR-6.4, PJpBR-3.2, and F,-12 are encephalitogenic, as
described (2, 3, 5). T cell clones PJB-18, PJH-1.5, and F,-21 are nonencephalitogenic
(8). Other NHz-terminal MBP-specific Tcell clones have notbeen tested in vivo.
minal MBP-specific KJ16' T cell clones use the same 0 chain V-DJ combination
and to identify which member(s) of the Vp8 subfamily is used. A blot of Xba I
digested genomic DNA isolated from several of these clones was screened with
a probe, designated Vpc:5.1 (11), which is specific for the Vs8(Vp(,5) subfamily. This
probe hybridizes to all three V08 genes, Vg8., being 92 and 85% homologous to
V08.2 and V#8.:3, respectively (15). On germline DNA digested with Xba I, Vs8.,,
V08.2, and Vp8.3, genes are located on separate 10 .0-, 5.5- and 3.9-kb fragments,
respectively. In Fig. 3 a, it can be seen that there are rearrangements of a Vs8
subfamily member of KJ16+ clones PJR-25, PJB-18, and PJpR-6.2. A germline
configuration for all V08 members is observed for the KJ16- clone PJpR-6 .4.
The sizes of these rearranged bands are consistent with all the KJ16+ clones
using Vp8.2. To confirm this possibility, a blot of Xba I digested DNA was also
Clone* Antigens for
selection
Class II
restriction
MBP
specificity KJ16 F23.1
PJR-25 Rat MBP I-A" 1-9 + +
PJB-18 Bovine MBP I-A" 1-9 + +
PJB-20 Bovine MBP I-A" 1-9 + +
PJH-1.5 Human MBP I-A" 1-9 + +
PJH-2.4 Human MBP I-A" 1-9 + +
PJH-3.2 Human MBP I-A" 1-9 + +
PHJ-4.4 Human MBP I-A" 1-9 + +
PJpR-2.2 pRl-11 I-A" 1-9 + +
PJpR-5.2 pRl-11 I-A" 1-9 + +
PJpR-6.2 pRl-11 I-A" 1-9 + +
PJpR-7.5 pRl-11 I-A" 1-9 +
PJpBR-2.5 pBRI-11 I-A" l-9 + +
PJpBR-3.2 pBRI-11 I-A" 1-9 + +
PJpBR-5.2 pBRI-11 I-A" 1-9 + +
PJpR-5.3 pRl-Il 1-A" 1-9 - -
PJpR-6.4 pRl-11 I-A" 1-9 - -
PJpBR-3.1 pBRI-11 I-A" 1-9 - -
PJpBR-4.1 pBRI-11 I-A" 1-9 - -
F,-21 RatMBP I-A" I-9 + +
F,-12 Rat MBP I-A" 1-9 - -ZAMVIL ET AL .
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FIGURE 3. Examination of
TCR (3 chains by Southern
analysis . Above is a genomic
restriction enzyme diagram
for the region encoding the
TCR V, 3s (1la, 27) genes and
the region encoding TCR Do,
Jy, and Co genes (28) . Individ-
ual DNA probes used are
indicated below. All clones
are KJ16+ except PJpR-6 .4 .
(a) DNA was digested with
restriction enzyme Xba I and
hybridized with probe V#c5 .,,
a 280-bp Pst-Pvu II subclone
Of V#8.1 (VOC5., [reference 111) .
(b) Each DNA sample was
digested with Xba I and
hybridized with DNA probe
5'Vdcs .2, a 0.5-kb Pvu II frag-
ment, located 2 kb 5' of V ss .2
(see restriction map) . (c) DNA
was digested with Hind III
and hybridized with Vsc5., . (d)
DNA samples were digested
with Hind III and hybridized
with a 1 .2-kb Jag genomic
probe (12) encompassing
J,32,,_2 .7 . Va5 .1, which is not
shown, is located between
V0 .s and V0s , 2 (27) .
probed with a 0.5-kb Pvu TI fragment (11 a) located 2 kb 5' to V#a .2 (see restric-
tion map, Fig . 3) . A rearrangement detected using this 0.5-kb probe is specific
for the use of V#a.2 . Rearrangement of the V#8 .2 gene is observed for all four
KJ16 + clones examined by hybridization with this 0.5-kb probe (Fig . 3 b) .
Another KJ16 + clone, encephalitogenic clone PJpBR-3 .2 (Table I), which has
been examined in the same manner (not shown), also uses TCR V08 .2-
The sizes of the fragments seen on DNA digested with Xba I are consistent
with the use of members of the J 02 locus . To confirm this, blots were made from
DNA digested with Hind III . V0 8 .2 and V,38 .3 are both located on the same 9.6-
kb Hind III fragment . Vg&i is located on a 1 .2-kb fragment . Using Vs8.2, a rear-
rangement involving Js, produces a Hind III fragment of 13-14 kb, whereas
rearrangement involving Jp2 produces a Hind III fragment of 8-10 kb . Blots
made from DNA digested with Hind III were hybridized with the probe
VX5.1(Vss.1) (Fig . 3 c) and aJ,Y2-specific probe (12) (Fig. 3 d) . The 1 .2-kb fragment
containing V,3s ., has migrated off these gels . The rearranged bands seen by
hybridization with both J02 and V#C5AVas .1) probes are 8.5-9 .5 kb, indicating
that each rearrangement of V08 .2 is a Vs8.2DJO2 rearrangement . Two patterns of1592
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rearrangements were seen with the V# and Ja probes indicating that two different
J0 genes at the second J0 cluster must be used. Results of an Eco RV blot (not
shown) also indicate the use of two separate J# genes. The rearrangement of
clone PJR-25 is like that of PJB-18 and the rearrangement of clone PJB-20 is
the same as PJpR-6.2.
T cell clone PJB-18 has TCR 0 chain rearrangements involving the V.8 locus
on both homologous chromosomes. One rearrangement uses VB8.2 (Fig. 3, a and
b) and a separate rearrangement is consistent with the use of Vp8.3 (Fig. 3 a) . The
two V-DJ rearrangements have resulted in the deletion of both germline V08.,
and V,18.2 bands. T cell clone PJpR-6.2 has deleted all of the members of the
V,38 gene subfamily on one chromosome and has a rearrangement to V08.2 on the
other, leaving one germline copy of the V08.3 gene on that chromosome (Fig. 3
a) . With a J,I-specific probe, it was shown that this clone uses a J0, gene for the
V-DJ rearrangement on the other chromosome (results not shown). Both chro-
mosomes can rearrange TCR genes, though in accordance with allelic exclusion
(16), only one is productive. Of the two rearrangements for PJB-18 and PJpR-
6.2, the V08.2-containing rearrangement must be the functional one because both
clones react with KJ16, which recognizes V08.1 and V08.2, but not V08.3.
In Vivo Administration of an mAb Specific for the TCR V08 Subfamily Prevents
Induction of T Cell-mediated Autoimmune Encephalomyelitis. In previous studies,
antibodies specific for class II molecules (17-19) and antibodies specific for the
T,,, subset marker L3T4 (20) have been shown to be effective in preventing EAE
as well as other autoimmune diseases (21, 22). Although antigen-specific T cells
participate in the pathogenesis of each of these diseases, antibodies specific for
the antigen-specific TCR have not been tested for their potential role in therapy
of autoimmune disease. We have examined whether V08-Specific mAb F23.1 can
inhibit EAE. The results in Fig. 4 demonstrate that mAb F23.1 inhibits in vitro
proliferation of a representative V08+ T cell clone, but not a representative V08 -
clone. TCR V08-specific mAb F23.1 has been tested in vivo. In two separate
experiments, none of six and none of ten mice injected with F23.1 developed
EAE after injection of encephalitogenic clone PJR-25 (Table II). However,
100% of mice in these experiments that were given PJR-25 without F23.1 (or
injected with an isotype-matched control mouse mAb) developed chronic paral-
ysis in the same manner as we have described previously (2, 3). In contrast,
administration of F23.1 into SJL/J mice (not shown), which lack the V08 subfam-
ily, does not prevent EAE.
0
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FIGURE 4. TCR V, 3s-specific mAb F23.1
inhibits proliferation of Vs8+ T cell clone
PJR-25. 10' Vy8+ MBP 1-11-specific clone
PJR-25 (IM and Vy8- MBP35-47-specific
clone F3.3 (O were cultured with 6.7-,M
antigen (either MBP 1-11 or MBP35-47) in
the presence of various concentrations of
V.,8-specific mAb F23.1 . (PLSJ)F, splenic
antigen-presenting cells were used foreach
incubation. Antigen and mAb F23.1 were
added at the beginning of the culture
period. Proliferative responses were deter-
mined as described in Materials and
Methods.ZAMVIL ET AL.
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TABLE II
In Vivo Administration of an mAb SpecificfortheAntigen-specific
TCR Prevents Induction ofEAE
Induction of EAE by encephalitogenic T cell clone PJR-25 has been
described previously (2, 3) . Recipient (PLSJ)Fl mice were injected intra-
peritonealy with 500 ug DEAE column-purified mAb F23.1 or 500 wg of
an isotype-matched (-y2a) control mouse mab S5.2 (anti-Leu-5b [Becton-
Dickinson Immunocytometry, Fullerton, CA]). Control mice (in experi-
ment 1) were injected intraperitonealy with 1.0 ml PBS. 6 hlater, recipient
mice were injected with 5 X 106 cells of encephalitogenic clone PJR-25.
Mice were examined daily by two independent observers. Severity of EAE
was graded as follows: 0, no sign of EAE; 1, decreased tail tone only; 2,
mild paraparesis; 3, moderately severe paraparesis; 4, complete paraple-
gia; 5, moribund.
* Injected with 500 wg mAb F23.1 14 d afterinjection of PJR-25.
Discussion
EAE is a model for T cell-mediated autoimmune disease. In previous studies,
we have identified MBP-specific T lymphocyte clones that mediate EAE, causing
relapsing paralysis and demyelination within the central nervous system (2, 3).
We have shown that these clones recognize the NH2-terminal-nine residue pep-
tide of MBP, and this peptide is the dominant encephalitogenic T cell epitope
for both PL/J and (PLSJ)Fl mice (5). T lymphocyte recognition of this epitope
is restricted by I-A° class II molecules (5, 8). In this report, we have investigated
TCR 0 chain expression of individual T cell clones that express this phenotypic
self antigen specificity and MHC class II (I-A°) restriction. Both examination of
TCR expression with TCR (3 chain-specific antibodies and molecular analysis
with TCR V# chain gene probes have shown that the encephalitogenic T cell
response is not genetically clonal, as both Vp8+ and Vss- T cell clones recognize
MBP1-9. Our results indicate, however, there is a restricted TCR ,d chain expres-
sion in the autoimmune response to the encephalitogenic NH2 terminus of
MBP. There is a predominant expression of the TCR Vgs subfamily, in particular
Vss.2. In another study, predominant usage of a Vo gene was observed for T cell
clones that share the same fine specificity the COON-terminal epitope of cyto-
chrome c (23) . Whether the predominant use of a particular VO or V. subfamily
reflects a unique Ag/MHC specificity or MHC class II restriction alone is not
yet clear (24). We are currently examining TCR Vs expression of T cells that
recognize other epitopes of MBP and have different class II restriction patterns
(3). It is possible, however, that predominant expression of an individual TCR
V,, (or V.) may be relevant to diagnosis and treatment of T cell-mediated
Exp. mAb Incidence Severity Day of
onset
1 F23.1 0/6
- 6/6 3.5 42
2 F23.1 0/5 - -
F23.1 0/5* - -
S5.2 5/5 4.0 271594 T CELL RECEPTOR Vy GENE EXPRESSION IN AUTOIMMUNITY
autoimmune disease. In this report, we have investigated whether an antibody
to the antigen-specific TCR may have application to therapy of autoimmune dis-
ease. Our results demonstrate that in vivo administration of a TCR Vas-specific
mAb can prevent T cell-mediated autoimmune encephalomyelitis. Thus, in clin-
ical situations where autoaggressive T cells can be identified, antibodies to the
Ag/MHC TCR may provide a more specific form of therapy.
The results in this report demonstrate the importance of examining both phe-
notypic Ag/MHC specificity as well as TCR gene rearrangement to assess het-
erogeneity in T cell-mediated diseases. In recent studies, T lymphocytes (with-
out known antigen specificity) have been isolated from the brain and
cerebrospinal fluid of MS patients, cloned in vitro, and examined by Southern
analysis with Jo and Co TCR gene probes. Those T cells clones did not rearrange
their TCR # chain genes in a strictly clonal manner (25, 26). However, in adop-
tive transfer studies of EAE (a model for MS), it has been shown that only a
small percentage of T cells within inflammatory CNS lesions are encephalito-
genic (29). Thus, identifying the relevant population of T cells may be extremely
difficult. Furthermore, observing separate TCR ,Q chain gene rearrangements
does not necessarily imply phenotypic differences in Ag/MHC specificity. It is
clear from our results that T lymphocyte clones that mediate autoimmune
encephalomyelitis express the same phenotypic self-antigen specificity and MHC
restriction, yet rearrange their DNA in a different manner, many using
V08.2-Dg-J02 combinations, and a minority of clones using a separate Vo gene.
Because most of these T cells use a common V Q gene, we have been able to test
a novel therapeutic approach, demonstrating for the first time that an antibody
to the antigen-specific TCR may have a role in the therapy of autoimmune
disease.
Summary
TCR 0 chain gene expression of individual T cell clones that share the same
MHC class II restriction and similar fine specificity for the encephalitogenic
NH2 terminus of the autoantigen myelin basic protein (MBP) has been exam-
ined. TCR V~ expression was examined by FRCS analysis with mAbs specific for
the Vg8 subfamily of TCR a chain genes. 14 of 18 (78%) NH2-terminal MBP-
specific clones examined express a member of the TCR V0s subfamily. Southern
analysis was used to identify which member(s) of the TCR V#H subfamily is
expressed by these clones. Each of four clones examined uses V.H.z, though two
different V08.2Js2 combinations were identified. Our findings indicate that there
is restricted TCR V# usage in the autoimmune T cell response to the dominant
encephalitogenic NH2-terminal epitope of the MBP. The use of an mAb to the
antigen-specific TCR in the prevention of T cell-mediated autoimmune disease
has been investigated. Our results demonstrate that in vivo administration of a
TCR Vas-specific mAb prevents induction of autoimmune encephalomyelitis.
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